# Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection

> **NCT05827328** · — · COMPLETED · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 2000 (actual)

## Conditions studied

- Thoracic Diseases
- Thoracic Surgery

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT05827328
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-29
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827328, "Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05827328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*